selected scholarly activity
-
books
- GI Epidemiology 2014
-
chapters
- Epidemiology, Microbiome, and Risk Factors Involved in Carcinogenesis of Colorectal Cancer. 146-148. 2024
- WHAT IS THE ROLE OF TRICYCLIC ANTIDEPRESSANTS IN THE TREATMENT OF IBS?. 183-185. 2024
- Diagnostic Studies. 106-112. 2014
- How to Read a Systematic Review and Meta‐Analysis. 48-57. 2014
- Randomized Controlled Trials. 113-118. 2014
- Dyspepsia: Ulcer and Non‐Ulcer/Bloating and Early Satiety/Belching and Rumination. 22-25. 2012
- Irritable Bowel Syndrome. 355-376. 2010
- Epidemiology and Prevention of Colorectal Cancer. 291-304. 2008
- Meta‐Analyses. 71-77. 2007
-
conferences
- Interactive training with a novel simulation model for upper gastrointestinal endoscopic hemostasis improves trainee technique and confidence. Endoscopy International Open. E245-E252. 2024
- Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology. 1206-1218. 2023
- Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Critical Care Medicine. 1175-1186. 2022
- Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-Analysis. American Journal of Gastroenterology. S141-S142. 2021
- OP05 Association of ultra-processed food intake with risk of Inflammatory Bowel Disease from the prospective urban rural epidemiology (PURE) study: A prospective cohort study. Journal of Crohn's and Colitis. S006-S006. 2021
- ASSOCIATION OF PROCESSED FOOD INTAKE WITH RISK OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. Gastroenterology. S81-S81. 2021
- FECAL IMMUNOCHEMICAL TEST (FIT) VERSUS CY(CY) IN DETECTING ADVANCED COLON NEOPLASIA: A DIAGNOSTIC TEST ACCURACY META-ANALYSIS INCLUDING A HEAD-TO-HEAD COMPARISON OF FIT AND CY. Gastroenterology. S204-S204. 2021
- INTESTINAL PERMEABILITY IN HEALTHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCIATED WITH ENVIRONMENTAL AND DEMOGRAPHIC FACTORS RATHER THAN CROHN'S DISEASE POLYGENIC RISK SCORE. Gastroenterology. S118-S118. 2021
- RESULTS OF THE FIRST PILOT RANDOMIZED CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR PEDIATRIC ULCERATIVE COLITIS. Gastroenterology. S89-S89. 2021
- IMPROVING PATIENT PARTICIPATION IN LONGITUDINAL RESEARCH: AN INNOVATIVE PATIENT-LED PATIENT-ORIENTED QUALITATIVE RESEARCH PROJECT TO UNDERSTAND THE MOTIVATIONS AND BARRIERS TO GETTING AND STAYING INVOLVED IN THE IMAGINE SPOR STUDY. Gastroenterology. S68-S69. 2021
- IMPROVING PATIENT PARTICIPATION IN LONGITUDINAL RESEARCH: AN INNOVATIVE PATIENT-LED PATIENT-ORIENTED QUALITATIVE RESEARCH PROJECT TO UNDERSTAND THE MOTIVATIONS AND BARRIERS TO GETTING AND STAYING INVOLVED IN THE IMAGINE SPOR STUDY. Inflammatory Bowel Diseases. S50-S50. 2021
- O61 Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. A34-A35. 2021
- Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 1441-1451. 2020
- PREVALENCE AND RISK FACTORS FOR LYMPH NODE METASTASIS AFTER NONCURATIVE ENDOSCOPIC RESECTION FOR EARLY ASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastrointestinal Endoscopy. AB586-AB587. 2020
- REDUCING ANXIETY IN PATIENTS UNDERGOING FIRST-TIME COLONOSCOPY: A PILOT AND FEASIBILITY STUDY FOR RANDOMIZED CONTROLLED TRIAL. Gastrointestinal Endoscopy. AB568-AB569. 2020
- CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY. Gastroenterology. S675-S676. 2020
- FEASIBILITY OF THE FIRST PAEDIATRIC RANDOMIZED CONTROLLED PILOT TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS. Gastroenterology. S972-S972. 2020
- RESULTS OF THE FIRST PAEDIATRIC RANDOMIZED-CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS. Gastroenterology. S132-S132. 2020
- THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. S1002-S1003. 2020
- THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS. Gastroenterology. S27-S27. 2020
- THE GEM PROJECT: IMPAIRED GUT BARRIER FUNCTION IS ASSOCIATED WITH FUTURE DEVELOPMENT OF CROHN'S DISEASE EVEN IN THE PRESENCE OR ABSCENCE OF PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S PATIENTS. Gastroenterology. S730-S731. 2020
- THE UTILITY OF GLUCOSE HYDROGEN BREATH TEST IN IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW. Gastroenterology. S848-S849. 2020
- Feasibility of the first paediatric randomised controlled pilot trial of faecal microbiota transplant for ulcerative colitis. Journal of Crohn's and Colitis. S353-S354. 2020
- Perceptions of faecal microbiota transplantation in patients with ulcerative colitis. Journal of Crohn's and Colitis. S335-S336. 2020
- Results of the first paediatric randomised controlled trial of faecal microbiota transplant for ulcerative colitis. Journal of Crohn's and Colitis. S379-S379. 2020
- Understanding Patients' Perceptions of Fecal Microbiota Transplant. American Journal of Gastroenterology. S5-S5. 2019
- 2885 Reducing Anxiety in Patients Undergoing First-Time Colonoscopy: A Pilot and Feasibility Study for a Randomized Controlled Trial. American Journal of Gastroenterology. S1581-S1581. 2019
- PWE-076 Efficacy of Pharmacological Therapies in Patients with Irritable Bowel Syndrome with Diarrhoea: Network Meta-analysis. Gut. A207-A208. 2019
- A RANDOMIZED TRIAL OF PROTON PUMP INHIBITORS VERSUS PLACEBO TO PREVENT UPPER GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING RIVAROXABAN OR ASPIRIN. Gastroenterology. S174-S174. 2019
- ADVERSE EVENTS RELATED TO PROTON PUMP INHIBITOR THERAPY. RESULTS OF A RANDOMIZED TRIAL OF PANTOPRAZOLE VERSUS PLACEBO WITH 53,152 PATIENT YEARS OF FOLLOW-UP. Gastroenterology. S173-S174. 2019
- EFFECTS OF PROTON-PUMP INHIBITORS IN PATIENTS RECEIVING CLOPIDOGREL-BASED ANTITHROMBOTIC THERAPY FOR CARDIOVASCULAR PREVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS. Gastroenterology. S97-S97. 2019
- ELEVATED FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH FUTURE DIAGNOSIS OF CROHN'S DISEASE. Gastroenterology. S413-S413. 2019
- INCREASED INTESTINAL PERMEABILITY IS A PREDICTOR OF CROHN'S DISEASE DEVELOPMENT IN A LARGE COHORT OF ASYMPTOMATIC FIRST DEGREE RELATIVES. Gastroenterology. S22-S22. 2019
- PATIENT PERCEPTIONS OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATENT OF ULCERATIVE COLITIS. Gastroenterology. S671-S672. 2019
- PROTON PUMP INHIBITOR TREATMENT INITIATED PRIOR TO ENDOSCOPY IC DIAGNOSIS IN UPPER GASTROINTESTINAL BLEEDING: AN UPDATED COCHRANE COLLABORATION SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Gastroenterology. S751-S751. 2019
- VALIDATION OF THE BRISTOL STOOL CHART AND THE BLISS STOOL CLASSIFICATION SYSTEM IN THE INTENSIVE CARE UNIT. Gastroenterology. S1073-S1073. 2019
- Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.. Journal of Clinical Oncology. LBA4008-LBA4008. 2018
- EXCLUSION DIETS AND IRRITABLE BOWEL SYMPTOMS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. S783-S783. 2018
- ROLE OF PROKINETICS IN SYMPTOM IMPROVEMENT OF FUNCTIONAL DYSPEPSIA: COCHRANE COLLABORATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Gastroenterology. S91-S92. 2018
- THE PREVALENCE OF CELIAC DISEASE IS INCREASED IN PATIENTS WITH BARRETT'S ESOPHAGUS AND IS ASSOCIATED WITH EARLY DEVELOPMENT OF DYSPLASIA. Gastroenterology. S680-S680. 2018
- PWE-124 Daily aspirin 300mg: how much do patients take? drug accountability for the first 5 years of the aspect study. Gut. A189-A189. 2017
- ANTIGLIADIN ANTIBODIES PREDICT THE SYMPTOMATIC RESPONSE TO GLUTEN-FREE DIET AND IMPROVEMENT IN GASTROINTESTINAL MOTILITY IN IBS PATIENTS. Gastroenterology. S45-S45. 2017
- Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia. Gastroenterology. S939-S939. 2017
- No Detrimental Effect of Oats on Symptoms, Histological Parameters, Serological Tests, or Quality of Life in Celiac Disease: A Systematic Review and Meta-Analysis. Gastroenterology. S481-S481. 2017
- PTU-149 Barrett’s Oesophagus Patients Attending Hospital: Baseline Clinical, Patient History and Quality of Life Data from Boss and Aspect. Gut. A130.3-A131. 2016
- Sa1199 Protease Inhibitors for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials. Gastrointestinal Endoscopy. AB252-AB252. 2016
- Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies. Gastroenterology. S743-S744. 2016
- Sa1085 Telephone vs. Clinic Follow-Up in the Management of Patients With Inflammatory Bowel Disease: A Nurse Practitioner Led Study. Gastroenterology. S235-S235. 2016
- Anxiety and depression may lead to poor health-related quality of life in patients with inflammatory bowel disease. Journal of Crohn's and Colitis. S154-S154. 2016
- Living with inflammatory bowel disease: results from focus group. Journal of Crohn's and Colitis. S499-S500. 2016
- P-079 YI The Association Between Anxiety and Depression and Health Related Quality of Life in Patients with Inflammatory Bowel Disease (IBD). Inflammatory Bowel Diseases. S34-S34. 2016
- P-231 YI Patient Experience Living with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. S79-S79. 2016
- Telephone vs clinic follow-up in the management of patients with inflammatory bowel disease: a nurse practitioner-led study. Journal of Crohn's and Colitis. S495-S495. 2016
- The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk. Value in Health. A625-A625. 2015
- Effect of Antidepressants on Sleep in Functional Dyspepsia. American Journal of Gastroenterology. S740-S741. 2015
- Anxiety and Depression Increase in a Step-Wise Fashion in Parallel With Multiple FGIDs. Gastroenterology. S654-S654. 2015
- Functional Dyspepsia Treatment Trial (FDTT): Association of Adequate Relief Response and Psychological Measures. Gastroenterology. S890-S891. 2015
- Functional Dyspepsia Treatment Trial (FDTT): Effect of Antidepressants on Mood Response in Functional Dyspepsia. Gastroenterology. S889-S889. 2015
- Gastric Physiology Test Correlations in Functional Dyspepsia. Gastroenterology. S50-S51. 2015
- Increased Risk of Functional Gastrointestinal Disorders (FGIDs) in Obesity Patients. Gastroenterology. S672-S673. 2015
- Is Proton Pump Inhibitor Use Associated With Delayed Gastric Emptying in Functional Dyspepsia Subjects?. Gastroenterology. S888-S888. 2015
- The Gut Microbiome in Patients with Anxiety, Depression and Inflammatory Bowel Disease. Neuropsychopharmacology. S289-S289. 2014
- A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.. Gastroenterology. S159-S159. 2014
- Dermatological Complications of Anti-TNF-alpha Therapy in Crohn's Disease. Gastroenterology. S583-S583. 2014
- GI Bowel Symptom Comorbidity in Functional Dyspepsia. Gastroenterology. S178-S179. 2014
- In Functional Dyspepsia, Are Meal-Related Symptoms Linked to Less Drinking Capacity?. Gastroenterology. S853-S854. 2014
- Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia. Gastroenterology. S470-S471. 2014
- Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial. Gastroenterology. S902-S902. 2014
- The Functional Dyspepsia Treatment Trial (FDTT): 5-HTT LPR and Gn beta 3 825C > T Are Not Pharmacogenetic Markers for FD Antidepressant Treatment Response. Gastroenterology. S179-S179. 2014
- P309 Transition experience from inpatient to ambulatory IBD care: Results of a pilot study. Journal of Crohn's and Colitis. S193-S194. 2014
- Double Guidewire Technique for the Prevention of Post-ERCP Pancreatitis (PEP): Cochrane Collaboration Meta-analysis of RCTs. American Journal of Gastroenterology. S60-S60. 2013
- Psychosocial Characteristics of Patients With IBD: Experience From the Mcmaster Interdisciplinary Clinic. Gastroenterology. S651-S651. 2013
- Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects. Gastroenterology. S57-S57. 2013
- The Functional Dyspepsia Treatment Trial (Fdtt) Key Results. Gastroenterology. S140-S140. 2013
- The Relationship Between Common IBD-Associated Risk Alleles and Intestinal Permeability in a Cohort of Healthy First Degree Relatives of Individuals With Crohn's Disease. Gastroenterology. S835-S835. 2013
- PPI and antiplatelet Co-therapy: What does the current evidence show?. Journal of Gastroenterology and Hepatology. 34-34. 2012
- Electrosurgical Current for Endoscopic Biliary Sphincterotomy (EBS) for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-analysis of Randomized Controlled Trials. American Journal of Gastroenterology. S719-S720. 2012
- Disordered Eating Behaviors in Functional Dyspepsia Patients. Gastroenterology. S612-S612. 2012
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report. Gut. 646-664. 2012
- Risk of Serious (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Low-Dose Aspirin: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. Gastroenterology. S464-S464. 2012
- Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant Non-Selective NSAID and Anticoagulation Therapy for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. Gastroenterology. S499-S499. 2012
- Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Clopidogrel for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. Gastroenterology. S463-S463. 2012
- Risk of Serious Upper Gastrointestinal (UGI) Complications With use of Non-Selective (NS) NSAIDs for at Least 4 Weeks Among Patients With a History of Peptic Ulcer (PU) or PU Complications: A Series of Systematic Reviews and Meta-Analyses. Gastroenterology. S501-S501. 2012
- Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Multiple Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials (RCT), Cohort and Case Control Studies. Gastroenterology. S501-S501. 2012
- Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. Gastroenterology. S192-S192. 2012
- Guidewire-Assisted Cannulation of the Common Bile Duct for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials. Gastrointestinal Endoscopy. 120-120. 2012
- Interdisciplinary, prompt access IBD clinic: The hamilton health science experience. Inflammatory Bowel Diseases. S7-S7. 2011
- Gender Differences in Psychologic Parameters in Functional Dyspepsia. American Journal of Gastroenterology. S504-S504. 2011
- Is the nutrient drink test associated with the patients' psychologic state?. Neurogastroenterology and Motility. 36-37. 2011
- Barrett's Dysplasia Cancer Task Force - Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus. Gastroenterology. S178-S178. 2011
- Comparing the Quality of Reporting in Randomized Controlled Trial Abstracts at Two International Gastroenterology Meetings in 2010. Gastroenterology. S569-S569. 2011
- Efficacy of Antidepressants in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis Controlling for Depression. Gastroenterology. S209-S209. 2011
- ROME III Criteria for Functional Gastrointestinal Disorders: Too Much Overlap to Be Useful?. Gastroenterology. S725-S726. 2011
- Efficacy of antidepressants in irritable bowel syndrome: an updated systematic review and meta-analysis controlling for depression. Gut. A154-A155. 2011
- Rome III criteria for functional gastrointestinal disorders: too much overlap to be useful?. Gut. A25-A25. 2011
- Determining the Optimum Outcome for Trials Evaluating Symptom Improvement in Functional Gastrointestinal Disorders. American Journal of Gastroenterology. S492-S493. 2010
- Effect of Comorbidity on Mortality in Patients with Peptic Ulcer Bleeding - A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. S40-S40. 2010
- Quadruple Therapy Using a 3-in-1 Capsule of Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline with Omeprazole Compared to Triple Therapy for the Eradication of Helicobacter pylori: 2010 Presidential Poster. American Journal of Gastroenterology. S44-S44. 2010
- A Validation Study of the Italian Short-Form Leeds Dyspepsia Questionnaire. Gastroenterology. S483-S483. 2010
- Efficacy and Optimum Dose of Amino-Salicylic Acid (ASA) in Ulcerative Colitis (UC): A Meta-Analysis of Randomized Controlled Trials Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease. Gastroenterology. S519-S519. 2010
- Efficacy of Amino-Salicylic Acid (ASA) in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease. Gastroenterology. S519-S519. 2010
- Efficacy of Anti-TNF alpha Therapy in Ulcerative Colitis (UC): A Meta-Analysis of Randomized Controlled Trials Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease. Gastroenterology. S519-S520. 2010
- Efficacy of Antibiotics at Inducing Remission in Active Ulcerative Colitis (UC): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). Gastroenterology. S520-S521. 2010
- Efficacy of Antibiotics in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials (RCTs) Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease. Gastroenterology. S521-S521. 2010
- Efficacy of Biologics in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease. Gastroenterology. S520-S520. 2010
- Efficacy of Budesonide in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials (RCTs) Assessing Remission Induction in Active Disease and Relapse Prevention in Quiescent Disease. Gastroenterology. S520-S520. 2010
- Improving Adherence to Guidelines When Managing Non-Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Strategy. Gastroenterology. S327-S327. 2010
- Incidence of Inflammatory Bowel Disease Following the Walkerton Outbreak of Waterborne Bacterial Gastroenteritis. Gastroenterology. S145-S145. 2010
- Placebo Response Rates in Trials of Pharmacological Therapies for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Gastroenterology. S231-S231. 2010
- The Gamma-Aminobutyric Acid (GABA) Receptor Agonist Baclofen in the Treatment of Gastroesophageal Reflux Disease (GERD): A Systematic Review. Gastroenterology. S650-S650. 2010
- The Practice of North-American Gastroenterologists in Treating IBD Patients With C.Difficile: Antibiotics Alone or Combined Antibiotics-Immunomodulators?. Gastroenterology. S699-S699. 2010
- P.30 A VALIDATION STUDY OF THE ITALIAN SHORT-FORM LEEDS DYSPEPSIA QUESTIONNAIRE. Digestive and Liver Disease. S113-S113. 2010
- Does Proton Pump Inhibitor (PPI) Treatment Initiated Before Endoscopy Work in Unselected Upper Gastrointestinal Bleeding? A Cochrane Systematic Review Update. Gastroenterology. A44-A44. 2009
- Effect of Validation Status and Type of Dyspepsia Questionnaire On the Prevalence of Dyspepsia: Systematic Review and Meta-Analysis. Gastroenterology. A493-A493. 2009
- Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care. Gastroenterology. A439-A440. 2009
- Post-Infective Dyspepsia Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE). Gastroenterology. A59-A59. 2009
- Prevalence of Clinically Significant Endoscopic Findings in Individuals with and Without Dyspepsia: Systematic Review and Meta-Analysis. Gastroenterology. A488-A488. 2009
- Prevalence of Irritable Bowel Syndrome in Individuals with Dyspepsia: Systematic Review and Meta-Analysis. Gastroenterology. A149-A149. 2009
- Prevalence of Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Gastroenterology. A161-A162. 2009
- Prognosis of Post-Infectious Irritable Bowel Syndrome (PI-IBS) Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE). Gastroenterology. A629-A629. 2009
- Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care. Gastroenterology. A435-A435. 2009
- Risk Factors for Dyspepsia: Systematic Review and Meta-Analysis. Gastroenterology. A58-A58. 2009
- The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial. Gastroenterology. A439-A439. 2009
- The Worldwide Prevalence of Dyspepsia: Systematic Review and Meta-Analysis. Gastroenterology. A182-A182. 2009
- What Is the Optimum Duration of Proton Pump Inhibitor (PPI)-Based Triple Therapy for Helicobacter pylori? 7, 10, or 14 Days?. Gastroenterology. A342-A342. 2009
- Yield of Diagnostic Tests for Celiac Disease in Dyspepsia: Systematic Review and Meta-Analysis. Gastroenterology. A149-A149. 2009
- Efficacy of 5HT3-Antagonists in non-constipation predominant irritable bowel syndrome: systematic review and meta-analysis. American Journal of Gastroenterology. S477-S477. 2008
- Efficacy of 5HT4-Agonists in Non-Diarrhea Predominant Irritable Bowel Syndrome. American Journal of Gastroenterology. S478-S478. 2008
- Efficacy of Antidepressants in Irritable Bowel Syndrome. American Journal of Gastroenterology. S476-S477. 2008
- Efficacy of antispasmodics and peppermint oil in irritable bowel syndrome: Systematic review and meta-analysis. American Journal of Gastroenterology. S459-S459. 2008
- The Efficacy of Probiotics in the Therapy of Irritable Bowel Syndrome (IBS). American Journal of Gastroenterology. S481-S481. 2008
- Triple Versus Quadruple Therapy as Primary Treatment for Heliobacter pylori Infection. American Journal of Gastroenterology. S397-S398. 2008
- Utility of Diagnostic Tests for Celiac Disease in Irritable Bowel Syndrome. American Journal of Gastroenterology. S463-S463. 2008
- Empirical proton pump inhibitor therapy or Helicobacter pylori "test and treat" in the initial management of dyspepsia? An individual patient data meta-analysis. Gastroenterology. A142-A143. 2008
- Fluctuation of gastrointestinal symptoms in the community: A 10-year longitudinal survey. Gastroenterology. A324-A324. 2008
- Helicobacter pylori eradication reduces the incidence of gastric cancer: Results of a systematic review of randomized controlled trials. Gastroenterology. A631-A632. 2008
- Systematic review and meta-analysis of the saftey of bismuth. Gastroenterology. A324-A324. 2008
- Systematic review of the utility of the manning and ROME criteria in the diagnosis of irritable bowel syndrome. Gastroenterology. A467-A467. 2008
- Economic Reflections on Proton Pump Inhibitor Therapy for Non-Erosive Reflux Disease. Digestion. 61-69. 2008
- Non-Erosive Reflux Disease – Defining the Entity and Delineating the Management. Digestion. 1-5. 2008
- Helicobacter pylori and related disease. Journal of Gastroenterology and Hepatology. A24-A24. 2007
- Who Pays the Piper?. Journal of Clinical Gastroenterology. S97-S101. 2007
- A cross-sectional survey to assess the usefulness of the Rome III dyspepsia symptom subgroups in a large community sample. Gastroenterology. A73-A73. 2007
- A cross-sectional survey to assess the usefulness of the rome III dyspepsia symptom subgroups in a large community sample. Gut. A56-A57. 2007
- Endoscopic Ultrasound: A Meta-Analysis of Test Performance in Suspected Choledocholithiasis. Gastrointestinal Endoscopy. AB360-AB360. 2007
- Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomised, double-blind, placebo-controlled multicentre study. Gut. A42-A42. 2007
- Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomized, double-blind, placebo-controlled multicenter study. Gastroenterology. A480-A480. 2007
- Evaluation of symptom relief after 1 week of esomeprazole therapy as a predictor of relief after 4 weeks in patients with unexplained chest pain: A randomized, double-blind, placebo-controlled, multicenter study. Gastroenterology. A483-A483. 2007
- Herbal medicine for the treatment of functional dyspepsia: A systematic review of the literature and meta-analysis. Gastroenterology. A682-A683. 2007
- Poor quality of life predicts the new onset of irritable bowel syndrome. A longitudinal 10-year follow-up study. Gut. A63-A63. 2007
- Poor quality of life predicts the new onset of irritable bowel syndrome. A longitudinal ten-year follow-up study. Gastroenterology. A674-A675. 2007
- Who consults with irritable bowel syndrome? A longitudinal 10-year follow-up study. Gut. A64-A64. 2007
- A 10 year natural history of gastrooesophageal reflux disease. Gut. A63-A64. 2006
- A cross sectional survey of the relationship between gastrooesophageal reflux disease and chronic cough. Gut. A64-A64. 2006
- A ten-year natural history of gastro-esophageal reflux disease. Gastroenterology. A455-A455. 2006
- Effect of sibling number and birth order on Helicobacter pylori prevalence: A cross sectional survey. Gut. A63-A63. 2006
- Effect of sibling number and birth order on prevalence of Helicobacter pylori a cross-sectional survey. Gastroenterology. A460-A460. 2006
- H-pylori eradication v empirical acid suppression in uninvestigated H-pylori positive dyspepsia: A Cochrane Collaboration individual patient data meta-analysis. Gastroenterology. A38-A38. 2006
- Helicobacter pylori infection confers an increase in 10 year mortality from all causes: Data from a community screening programme. Gut. A26-A26. 2006
- Helicobacter pylori infection confers an increase in ten-year mortality from all causes: Data from a community screening and treatment program. Gastroenterology. A459-A459. 2006
- High dose versus standard dose proton pump inhibitors in the short term management of reflux esophagitis. Cochrane Database of Systematic Reviews. A177-A177. 2006
- Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in unselected upper gastrointestinal bleeding: A cochrane systematic review and meta-analysis. Gastroenterology. A122-A122. 2006
- Systematic review of adenocarcinoma risk in Barrett's esophagus with particular reference to short segment Barrett's esophagus and intestinal metaplasia. Gastroenterology. A264-A264. 2006
- Targeted esophageal biopsies: What you see is what you get (WYSIWYG) - Or not?. Gastroenterology. A161-A162. 2006
- Who consults with dyspepsia? A 10 year cross sectional survey. Gut. A36-A36. 2006
- Who consults with dyspepsia? A ten-year cross-sectional survey. Gastroenterology. A38-A38. 2006
- A community screening and treatment programme for H-pylori saves money: Ten-year follow-up of a randomized controlled trial. Gastroenterology. A95-A96. 2005
- A systematic review of the diagnosis of functional dyspepsia. Gastroenterology. A157-A157. 2005
- Ten year follow-up of a community screening and treatment programme for H pylori. Gut. A60-A60. 2005
- The diagnostic value of alarm features in predicting upper gastrointestinal malignancy in dyspeptic patients: Systematic review and meta-analysis.. Gastroenterology. A80-A80. 2005
- Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004. Canadian Journal of Gastroenterology and Hepatology. 15-35. 2005
- A retrospective case control study to determine the risk of Barrett's oesophagus according to ethnic origin. Gut. A26-A26. 2004
- A retrospective case-control study to determine the risk of Barrett's esophagus according to ethnic origin. Gastroenterology. A114-A114. 2004
- Methodologic quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia: A meta-analysis based on two methodologic criteria scores. Gastroenterology. A604-A604. 2004
- Mortality risk factors and comorbidity in patients with Barrett's metaplasia. Gut. A62-A62. 2004
- Prompt endoscopy versus a 'test and treat' strategy in the initial management of dyspepsia: An individual patient data meta-analysis of randomized controlled trials. Gastroenterology. A70-A70. 2004
- The long-term natural history of dyspepsia, and the importance of the irritable bowel syndrome. Gastroenterology. A439-A439. 2004
- A systematic review and economic analysis of the cost-effectiveness of proton pump inhibitor therapy in non-ulcer dyspepsia. Gut. A16-A17. 2003
- A systematic review and economic analysis of the cost-effectiveness of proton pump inhibitor therapy in non-ulcer dyspepsia. Gastroenterology. A182-A182. 2003
- A systematic review of Helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance. Gastroenterology. A359-A359. 2003
- A systematic review of helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance. Gut. A17-A18. 2003
- A systematic review of the efficacy of proton pump inhibitors (PPIs), H2 receptor antagonists (H2RAs) and prokinetics in maintenance therapy of esophagitis. Gastroenterology. A108-A109. 2003
- Cost effectiveness of h pylori "test and treat" versus PPI for uninvestigated dyspepsia: Modelling and meta-analysis in the design of the MRC-CUBE trial. Gut. A80-A80. 2003
- Early diagnosis or prevention of gastric cancer with H.pylori ȁTest and treatȁ? A discrete event simulation model. Gastroenterology. A180-A181. 2003
- Gastroesophageal reflux is more prominent in western dyspeptics: A prospective comparison study of British and South East Asian patients with dyspepsia. Gastroenterology. A168-A168. 2003
- How best to assess symptomatic outcomes of therapy in gastro-oesophageal reflux disease trials: A systematic review. Gastroenterology. A72-A72. 2003
- How best to assess symptomatic outcomes of therapy in gastro-oesophageal reflux disease trials: A systematic review. Gut. A45-A45. 2003
- Survey of current clinical practice in the diagnosis, management and surveillance of Barrett's metaplasia: A UK national survey. Gut. A32-A32. 2003
- The value of drugs to treat upper gastrointestinal symptoms: What are patients willing to pay?. Gut. A81-A81. 2003
- Validation of the short-form leeds dyspepsia questionnaire (SF-LDQ) in a community setting. Gastroenterology. A224-A224. 2003
- Helicobacter pylori eradication in non-ulcer dyspepsia: the case for. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002. 265-274. 2003
- How can the current strategies for eradication therapy be improved?. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002. 401-411. 2003
- Clinical and economic consequences of dyspepsia in the community. Gut. iv10-iv12. 2002
- Helicobacter pylori test and treat strategy for young dyspeptic patients: new data. Gut. iv47-iv50. 2002
- A comparison of systematic reviews of Helicobacter pylori eradication for non-ulcer dyspepsia. Gut. A7-A8. 2002
- The effect of reduced duality of life on the subsequent development of dyspepsia and irritable bowel syndrome: A prospective cohort study. Gastroenterology. A102-A102. 2002
- The effect of reduced quality of life on the subsequent development of dyspepsia and irritable bowel syndrome: A prospective cohort study. Gut. A9-A9. 2002
- The influence of antibiotics on irritable bowel syndrome: A randomised controlled trial. Gut. A24-A24. 2002
- The influence of antibiotics on irritable bowel syndrome: A randomised controlled trial. Gastroenterology. A465-A466. 2002
- Patient preference and willingness to pay for helicobacter stool antigen test compared to breath test. Gut. A103-A103. 2001
- Helicobacter pylori: A clinical update. Journal of Applied Bacteriology Symposium Supplement. 2001
- Effectiveness of prompt endoscopy in the management of dyspepsia: A systematic review.. Gastroenterology. A239-A239. 2001
- The appropriateness of measuring the benefit of dyspepsia management in terms of quality adjusted life years. Gastroenterology. A239-A239. 2001
- The appropriateness of measuring the benefit of dyspepsia management in terms of quality adjusted life years. Gut. A33-A34. 2001
- A systematic review and economic analysis of the cost-effectiveness of H pylori eradication therapy in non-ulcer dyspepsia (NUD). Gastroenterology. A471-A471. 2000
- A systematic review and economic analysis of the cost-effectiveness of H pylori eradication therapy in non-ulcer dyspepsia (NUD). Gut. A51-A51. 2000
- A systematic review of pharmacological therapies in non-ulcer dyspepsia. Gastroenterology. A440-A440. 2000
- A systematic review of pharmacological therapies in non-ulcer dyspepsia.. Gut. A88-A88. 2000
- Cost-effectiveness of strategies for managing dyspepsia in primary care: A discrete event simulation. Gastroenterology. A468-A469. 2000
- Diagnosis of helicobacter pylori infection in acute upper gastrointestinal haemorrhage; what is the best diagnostic test?. Gastroenterology. A1245-A1245. 2000
- Establishing patient preferences for one-stop gastrointestinal clinics using conjoint analysis. Gastroenterology. A722-A722. 2000
- Establishing patient preferences for one-stop gastrointestinal clinics using conjoint analysis. Gut. A49-A49. 2000
- How much are dyspeptic patients willing to pay for endoscopy compared with H pylori "test and treat" service?. Gut. A18-A18. 2000
- How much are patients with dyspepsia willing to pay for endoscopy compared with an H pylori "test and treat" service?. Gastroenterology. A462-A462. 2000
- Knowledge of a negative C-13-urea breath test reduces health care utilisation for dyspepsia in a population H pylori test and treat program.. Gastroenterology. A678-A678. 2000
- Managing dyspepsia in primary care: A systematic review. Gastroenterology. A1249-A1249. 2000
- Supine duodeno-gastro-oesophageal bile reflux measured with the Bilitec-2000 appears to protect against the presence of microscopic intestinal metaplasia at the cardia. Gastroenterology. A26-A26. 2000
- The cost-effectiveness of population H pylori screening and treatment to reduce mortality from gastric cancer and peptic ulcer complications: A Markov model using randomized controlled trial data.. Gastroenterology. A678-A678. 2000
- The prevalence of Helicobacter pylori in bleeding peptic ulcer disease. Gut. A77-A77. 1999
- Accuracy of a new antigen based stool test for Helicobacter pylori (HP) in 117 endoscoped patients before and after treatment, European multicentre study.. Gut. A96-A96. 1999
- Addition of metronidazole to omeprazole and amoxicillin for second line H pylori eradication does not influence eradication rate: Results of a single-blinded randomised trial. Gastroenterology. A266-A266. 1999
- An evidence-based appraisal of reflux disease management --- the Genval Workshop Report. Gut. S1-S16. 1999
- Changing patterns of H pylori gastritis in long-standing acid suppression. Gastroenterology. A257-A257. 1999
- Changing patterns of H-pylori gastritis in long-standing acid suppression. Gut. A117-A117. 1999
- Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomised double blind study. Gastroenterology. A117-A117. 1999
- Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomised double blind study.. Gut. A112-A112. 1999
- H pylori screening and treatment reduces dyspepsia in the community. Gastroenterology. A81-A81. 1999
- H pylori screening and treatment reduces dyspepsia in the community.. Gut. A119-A119. 1999
- Population H pylori screening and treatment reduces dyspepsia costs.. Gut. A96-A96. 1999
- Population H pylori screening and treatment reduces dyspepsia costs.. Gastroenterology. A466-A466. 1999
- Second-line eradication for H-pylori after failure of therapy with proton pump inhibitor (PPI), clarithromycin and metronidazole: Results of a case series. Gastroenterology. A266-A266. 1999
- Second-line eradication for H-pylori after failure of therapy with proton pump inhibitor (PPI), clarithromycin and metronidazole: Results of a case series.. Gut. A3-A3. 1999
- Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for H-pylori eradication - Results of a single-blinded randomised trial in the community. Gastroenterology. A266-A266. 1999
- Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for H-pylori eradication - Results of a single-blinded randomised trial in the community.. Gut. A120-A120. 1999
- The cost-effectiveness of an H pylori screen and treat strategy in dyspeptic patients presenting in primary care. Gastroenterology. A257-A257. 1999
- The cost-effectiveness of an H-Pylori screen and treat strategy in dyspeptic patients presenting in primary care.. Gut. A1-A1. 1999
- The prevalence and severity of irritable bowel syndrome (IBS) in the community in those with and without a primary care diagnosis. Gastroenterology. A47-A47. 1999
- The prevalence and severity of irritable bowel syndrome (IBS) in the community in those with and without a primary care diagnosis.. Gut. A13-A13. 1999
- Why do irritable bowel syndrome (IBS) sufferers visit a primary care physician?. Gastroenterology. A81-A81. 1999
- Screening and treating for H-pylori - Is it cost-effective in clinical practice?. Gut. A114-A114. 1998
- Any role left for invasive tests? Histology in clinical practice. Gut. S51-S55. 1998
- The effectiveness and side effects of omeprazole, clarithromycin and tinidazole used in a community Helicobacter pylori eradication programme.. Gastroenterology. A231-A231. 1998
- The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community.. Gastroenterology. A231-A231. 1998
- What proportion of dyspepsia in the general population is attributable to Helicobacter pylori?. Gastroenterology. A231-A231. 1998
- Can pets ACT as a vector for Helicobacter pylori transmission?. Gastroenterology. A230-A231. 1998
- Response to pantoprazole is an effective diagnostic test for gastro-esophageal reflux disease: Results of a randomised double-blinded placebo-controlled pilot study. Gastroenterology. A242-A242. 1998
- Can pets act as a vector for Helicobacter pylori transmission?. Gut. A78-A78. 1998
- The effectiveness and side effects of a community Helicobacter pylori eradication programme.. Gut. A75-A75. 1998
- The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community.. Gut. A76-A76. 1998
- What proportion of dyspepsia in the general population is attributable to Helicobacter pylori?. Gut. A75-A75. 1998
- Effectiveness of omeprazole, clarithromycin and tinidazole against Helicobacter pylori in a community screening and eradication programme. Gut. A213-A213. 1997
- Evidence for intrafamilial transmission of Helicobacter pylori infection in adults. Gut. A103-A103. 1997
- Helicobacter pylori and the risk of stroke. Gut. A109-A109. 1997
- Influence of Helicobacter pylori status on adult height. Gut. A34-A34. 1997
- Isolation of H-pylori from gastric juice. Gut. A18-A19. 1997
- Validation of a new one-step near patient Helicobacter pylori test. Gut. A167-A167. 1997
- Accuracy of the Helisal rapid blood kit and its use in pre-endoscopic screening. Gut. A83-A83. 1997
- Evidence for intrafamilial transmission of Helicobacter pylori infection in adults. Gut. A37-A37. 1997
- Isolation of H-pylori from gastric juice. Gut. A40-A41. 1997
- Validation of a new one-step near patient Helicobacter pylori test. Gut. A85-A85. 1997
- Adult social class as an independent risk factor for Helicobacter pylori.. Gastroenterology. A210-A210. 1997
- Dyspepsia and irritable bowel syndrome in the community.. Gastroenterology. A223-A223. 1997
- Influence of siblings on risk of Helicobacter pylori infection.. Gastroenterology. A223-A223. 1997
- The optimum 5 day therapy against Helicobacter pylori.. Gastroenterology. A223-A223. 1997
- Adult social class as an independent risk factor for Helicobacter pylori.. Gut. F273-F273. 1997
- Dyspepsia and irritable bowel syndrome in the community.. Gut. F241-F241. 1997
- Influence of siblings on risk of Helicobacter pylori infection.. Gut. F272-F272. 1997
- The optimum 5 day therapy against Helicobacter pylori.. Gut. W18-W18. 1997
- Eradication ofHelicobacter pylori: Omeprazole in Combination with Antibiotics. Scandinavian Journal of Gastroenterology, Supplement. 82-89. 1996
- Whom, how and when to test for Helicobacter pylori infection. HELICOBACTER PYLORI. 269-285. 1996
- Efficacy of ten days of clarithromycin, amoxicillin and omeprazole in eradicating Helicobacter pylori infection. Gastroenterology. A169-A169. 1995
-
journal articles
- AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.. Gastroenterology. 167:1228-1238. 2024
- Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline.. The BMJ. 387:e079830. 2024
-
Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the
COMPASS randomised controlled trial. Alimentary Pharmacology and Therapeutics. 60:737-748. 2024 - Adverse Events Associated With Proton Pump Inhibitors: Fact vs Fiction.. Gastroenterology and Hepatology. 20:421-424. 2024
- Studying How Patient Engagement Influences Research: A Mixed Methods Study. Patient. 17:379-395. 2024
- The Effects of Pantoprazole on Kidney Outcomes. Journal of the American Society of Nephrology. 35:901-909. 2024
- Two Years Gone. Gastroenterology. 167:204-205. 2024
- Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterology and Motility. 36:e14817. 2024
- Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis. Gastroenterology. 167:934-943.e5. 2024
- Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project. Clinical Gastroenterology and Hepatology. 22:1889-1897.e12. 2024
- Measuring the Impact of Patient Engagement in Health Research: An Exploratory Study Using Multiple Survey Tools. Journal of the Canadian Association of Gastroenterology. 7:177-187. 2024
- Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study. Inflammatory Bowel Diseases. izae055. 2024
- Interactive training with a novel simulation model for upper gastrointestinal endoscopic hemostasis improves trainee technique and confidence. Endoscopy International Open. 12:E245-E252. 2024
- Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease. Journal of the Canadian Association of Gastroenterology. 7:68-77. 2024
- Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation. Therapeutic Advances in Chronic Disease. 15:20406223241239168. 2024
- The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. The 6 Ds of Fecal Microbiota Transplantation: A Primer From Decision to Discharge and Beyond. 118-123. 2024
- Psychosocial factors associated with j-pouch surgery for patients with IBD: a scoping review. Quality of Life Research. 32:3309-3326. 2023
- Exploring the outcomes of research engagement using the observation method in an online setting. BMJ Open. 13:e073953-e073953. 2023
- Microbiota signatures and mucosal healing in the use of enteral nutrition therapy v. corticosteroids for the treatment of children with Crohn’s disease: a systematic review and meta-analysis. British Journal of Nutrition. 130:1385-1402. 2023
- Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study. Clinical Gastroenterology and Hepatology. 21:2649-2659.e16. 2023
- Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives. Gastroenterology. 165:670-681. 2023
- Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis. Gut. 72:1462-1471. 2023
- What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 21:1739-1749.e2. 2023
- INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. Gastroenterology. 164:S136-S136. 2023
- Beyond the White Pill: Advocating for Racial Diversity in IBD Trials. Journal of Crohn's and Colitis. 17:459-461. 2023
- Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis. Gastroenterology. 164:619-629. 2023
- Working to Answer the Effectiveness of Nutrition in IBD: Still a Ways to Go. American Journal of Gastroenterology. 118:256-258. 2023
- Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia. Middle East Journal of Digestive Diseases. 15:5-11. 2023
- Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease. European Journal of Gastroenterology and Hepatology. 34:1210-1219. 2022
- Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease. Gastroenterology. 163:1364-1376.e10. 2022
- INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding. CJC OPEN. 4:996-1005. 2022
- Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis. Middle East Journal of Digestive Diseases. 14:382-395. 2022
- Reduce unnecessary use of proton pump inhibitors. The BMJ. 379:e069211-e069211. 2022
- Efficacy ofHelicobacter pylorieradication therapy for functional dyspepsia: updated systematic review and meta-analysis. Gut. 71:1967-1975. 2022
- Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply. Alimentary Pharmacology and Therapeutics. 56:1217-1218. 2022
- eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. Cancer Epidemiology, Biomarkers and Prevention. 31:1735-1745. 2022
- Analytical frameworks in colorectal cancer guidelines: development of methods for systematic reviews, their application and practical guidance for their use. Journal of Clinical Epidemiology. 149:206-216. 2022
- Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility. Nature Genetics. 54:1275-1283. 2022
- Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up. Gastroenterology. 163:754-756.e1. 2022
- Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation. Gastroenterology. 163:685-698. 2022
- Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics. 56:932-941. 2022
- A patient‐led, peer‐to‐peer qualitative study on the psychosocial relationship between young adults with inflammatory bowel disease and food. Health Expectations. 25:1486-1497. 2022
- Gastroenterology: A New Editorial Team Coming to You From Around the World. Gastroenterology. 163:1-2. 2022
- Diarrhea during critical illness: a multicenter cohort study. Intensive Care Medicine. 48:570-579. 2022
- Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database of Systematic Reviews. 2022:CD009662. 2022
- Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 5:12-17. 2022
- Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews. 2022:CD005415. 2022
- Reliability and Validation of the Persian Version of JUICE Study Questionnaire. Archives of Iranian Medicine. 25:1-5. 2022
- Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis: A Qualitative Assessment of Patient Perceptions and Experiences. Journal of the Canadian Association of Gastroenterology. 4:e120-e129. 2021
- Proton Pump Inhibitor Use: A Risk Factor for Inflammatory Bowel Disease or an Innocent Bystander?. Gastroenterology. 161:1789-1791. 2021
- Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study. European Journal of Gastroenterology and Hepatology. 33:e634-e641. 2021
- Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk. Gastroenterology. 161:1540-1551. 2021
- Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clinical Gastroenterology and Hepatology. 19:2343-2352.e8. 2021
- Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial. Journal of the Canadian Association of Gastroenterology. 4:214-221. 2021
- Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study. Gastroenterology. 161:1333-1335.e1. 2021
- Correction to: Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Gastroenterology. 116:1968-1968. 2021
- Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database of Systematic Reviews. 2021. 2021
- Results of the First Pilot Randomized Controlled Trial of Fecal Microbiota Transplant In Pediatric Ulcerative Colitis: Lessons, Limitations, and Future Prospects. Gastroenterology. 161:388-393.e3. 2021
- Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. The BMJ. 374:n1554-n1554. 2021
- Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma. Carcinogenesis. 42:369-377. 2021
- Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology. 160:1532-1545. 2021
- COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology. Journal of the Canadian Association of Gastroenterology. 4:49-49. 2021
- Current Status of Chemoprevention in Barrett’s Esophagus. Gastrointestinal Endoscopy Clinics of North America. 31:117-130. 2021
- Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms. Alimentary Pharmacology and Therapeutics. 53:253-264. 2021
- Leaving No Stone Unturned in the Search for Adverse Events Associated With Use of Proton Pump Inhibitors. Clinical Gastroenterology and Hepatology. 19:41-42. 2021
- Patients’ Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach. Clinical and Experimental Gastroenterology. Volume 14:123-131. 2021
- Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients. Frontiers in Physiology. 12:645303. 2021
- Systematic review and network meta‐analysis: efficacy of drugs for functional dyspepsia. Alimentary Pharmacology and Therapeutics. 53:8-21. 2021
- Helicobacter pylorieradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 69:2113-2121. 2020
- Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects. BMC Medical Genomics. 21:204. 2020
- Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease. Gastroenterology. 159:2092-2100.e5. 2020
- Who Needs Gastroprotection in 2020?. Current Treatment Options in Gastroenterology. 18:557-573. 2020
- IMAGINE Network’s Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome. BMJ Open. 10:e041733-e041733. 2020
- Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Gastroenterology. 115:1584-1595. 2020
- Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis. Gastroenterology. 159:884-903.e31. 2020
- Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis. Journal of Gastroenterology. 55:742-753. 2020
- Helicobacter pylorieradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews. 7:CD005583. 2020
- Evidence-based and mechanistic insights into exclusion diets for IBS. Nature Reviews Gastroenterology and Hepatology. 17:406-413. 2020
- How to advise patients on the risk of chronic proton pump inhibitor therapy. Current Opinion in Gastroenterology. 36:317-322. 2020
- Peppermint Oil in Irritable Bowel Syndrome. Gastroenterology. 159:395-396. 2020
- Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:98-99. 2020
- Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology. 158:930-946.e1. 2020
- Reply. Gastroenterology. 158:1175-1176. 2020
- Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology and Hepatology. 5:117-131. 2020
- Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data. Gastroenterology. 158:780-782.e3. 2020
- Development of a Global Rating Scale for Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:4-16. 2020
- Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:e1-e9. 2020
- Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews. 2020
- Controversies Around Measuring Drug Toxicity: US Food and Drug Administration and Gastrointestinal Perspectives. Gastroenterology. 158:22-27. 2020
- Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 69:74-82. 2020
- Is Blood Urea Concentration an Independent Predictor of Positive Endoscopic Findings in Presumed Upper Gastrointestinal Bleeding?. Digestive Diseases. 38:77-84. 2020
- Reply. Gastroenterology. 158:285-286. 2020
- Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem. Current Gastroenterology Reports. 21:65. 2019
- Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis. Circulation. 140:1451-1459. 2019
- Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn’s Disease. Inflammatory Bowel Diseases. 25:1796-1804. 2019
- Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease. ACP journal club. 171:JC45-JC45. 2019
- Faecal microbiota transplantation for IBS: still a long way to go. The Lancet Gastroenterology and Hepatology. 4:656-657. 2019
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. 157:682-691.e2. 2019
- Proton-pump inhibitors for the prevention of upper gastrointestinal bleeding in adults receiving antithrombotic therapy. Cochrane Database of Systematic Reviews. 2019. 2019
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. Clinical Gastroenterology and Hepatology. 17:1680-1713. 2019
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. Gastroenterology. 157:320-348. 2019
- Editorial: the overlap between dyspepsia and gastro‐oesophageal reflux—is duodenal eosinophilia the missing link?. Alimentary Pharmacology and Therapeutics. 50:454-455. 2019
- Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 157:403-412.e5. 2019
- Proton pump inhibitors and gastric cancer: association is not causation. Gut. 68:1529.2-1530. 2019
- Response to Letter by Moulton et al.. Inflammatory Bowel Diseases. 25:e99-e99. 2019
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. Journal of the Canadian Association of Gastroenterology. 2:e1-e34. 2019
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease. Journal of the Canadian Association of Gastroenterology. 2:e35-e63. 2019
- Gut Microbiota and Irritable Bowel Syndrome. Gastroenterology. 157:1-1. 2019
- Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review. Gastroenterology. 157:97-108. 2019
- Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 25:1255-1261. 2019
- Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study. BMJ Open. 9:e028237-e028237. 2019
- Letter: meta‐analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors’ reply. Alimentary Pharmacology and Therapeutics. 49:1254-1255. 2019
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). Journal of the Canadian Association of Gastroenterology. 2:6-29. 2019
- Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same Data. Journal of the Canadian Association of Gastroenterology. 2:30-36. 2019
- Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials. American Journal of Gastroenterology. 114:233-243. 2019
- Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus. Inflammatory Bowel Diseases. 25:1-13. 2019
- Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 114:21-39. 2019
- Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication. Journal of the Canadian Association of Gastroenterology. 1:155-158. 2018
- Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus. Journal of the Canadian Association of Gastroenterology. 1:141-154. 2018
- Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis. Gastroenterology. 155:1753-1763. 2018
- Imipramine for functional dyspepsia: a 60-year journey. The Lancet Gastroenterology and Hepatology. 3:815-817. 2018
- Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. 18:14. 2018
- Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics. 48:1044-1060. 2018
- Prokinetics for functional dyspepsia. Cochrane Database of Systematic Reviews. 2018:CD009431. 2018
- A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups. Gastroenterology Nursing. 41:427-435. 2018
- A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPS Diet in Treating Symptoms of Irritable Bowel Syndrome. American Journal of Gastroenterology. 113:1290-1300. 2018
- Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. The Lancet. 392:400-408. 2018
- FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. Gut Microbes. 9:1-12. 2018
- Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 3:71-92. 2018
- American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 113:1-18. 2018
- Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. The Lancet. 391:2325-2334. 2018
- Response to Marlicz et al. American Journal of Gastroenterology. 113:781-781. 2018
- Update on Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Disease.. Gastroenterology and Hepatology. 14:319-322. 2018
- Signature Celebration of Gastroenterology , Colorectal Cancer. Gastroenterology. 154:767-770. 2018
- Reply. Gastroenterology. 154:764-765. 2018
- Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry. Frontiers in Physiology. 9:1248. 2018
- Proton Pump Inhibitors and Dementia: Deciphering the Data. American Journal of Gastroenterology. 112:1809-1811. 2017
- Proton pump inhibitors for functional dyspepsia. Cochrane Database of Systematic Reviews. 2018:CD011194. 2017
- Prokinetics for functional dyspepsia. Cochrane Database of Systematic Reviews. 2017. 2017
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 377:1319-1330. 2017
- Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 66:1739-1747. 2017
- Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterology Journal. 5:773-788. 2017
- Systematic Review and Meta-analysis. Inflammatory Bowel Diseases. 23:1702-1709. 2017
- Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia. American Journal of Gastroenterology. 112:1484-1484. 2017
- Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.. Inflammatory Bowel Diseases. 23:1702-1709. 2017
- Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.. Medical Journal of Australia. 207:166-172. 2017
- Faecal microbiota transplantation for Clostridium difficile ‐associated diarrhoea: a systematic review of randomised controlled trials. Medical Journal of Australia. 207:166-172. 2017
- Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 153:448-459.e8. 2017
- Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial. Canadian Journal of Cardiology. 33:1027-1035. 2017
- Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 153:395-409.e3. 2017
- White Paper AGA: Functional Dyspepsia. Clinical Gastroenterology and Hepatology. 15:1191-1194. 2017
- ACG and CAG Clinical Guideline: Management of Dyspepsia. American Journal of Gastroenterology. 112:988-1013. 2017
- Antacids, sucralfate and bismuth salts for functional dyspepsia. Cochrane Database of Systematic Reviews. 2017. 2017
- Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. American Journal of Gastroenterology. 112:903-909. 2017
- Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.. Canadian Family Physician. 63:354-364. 2017
- Déprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.. Canadian Family Physician. 63:e253-e265. 2017
-
Editorial: latent class analysis to improve confidence in the diagnosis of
IBS – authors’ reply. Alimentary Pharmacology and Therapeutics. 45:1268-1269. 2017 - Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia. Scandinavian Journal of Gastroenterology, Supplement. 52:396-402. 2017
-
Letter:
NICE referral criteria for lower gastrointestinal alarm features – not ideal but not poor either. Authors' reply. Alimentary Pharmacology and Therapeutics. 45:1176-1176. 2017 - Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews. 2017:CD011969. 2017
- Proton pump inhibitors for functional dyspepsia. Cochrane Database of Systematic Reviews. 3:CD011194. 2017
- Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Alimentary Pharmacology and Therapeutics. 45:824-832. 2017
- Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 66:411-420. 2017
- Optimal strategies for pancreatic cyst surveillance: we need better comparative data, not more case series. Gastrointestinal Endoscopy. 85:685-686. 2017
- The gut microbiota and psychiatric illness. Journal of Psychiatry & Neuroscience. 42:75-77. 2017
- Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 2. Polskie Archiwum Medycyny Wewnetrznej. 127:137-138. 2017
- Microbiome: the beginning of understanding Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 1. Polskie Archiwum Medycyny Wewnetrznej. 127:135-136. 2017
- American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease. Gastroenterology. 152:648-664.e5. 2017
- Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 49:15-26. 2017
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report. Gut. 66:6-30. 2017
- Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis. Polskie Archiwum Medycyny Wewnetrznej. 127:137-138. 2017
- Microbiome: the beginning of understanding. Polskie Archiwum Medycyny Wewnetrznej. 127:135-136. 2017
- Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care. Alimentary Pharmacology and Therapeutics. 45:91-99. 2017
- Reply. Gastroenterology. 152:303-304. 2017
- Response to Feuerstein J et al. “Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005–2013) for Barrett’s Esophagus”. doi:10.1007/s10620-016-4222-2. Digestive Diseases and Sciences. 61:3369-3371. 2016
- Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. The Lancet Oncology. 17:1363-1373. 2016
- An index with improved diagnostic accuracy for the diagnosis of Crohn's disease derived from the Lennard‐Jones criteria. Alimentary Pharmacology and Therapeutics. 44:601-611. 2016
- Fecal transplantation. Current Opinion in Gastroenterology. 32:282-286. 2016
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 151:51-69.e14. 2016
- Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database of Systematic Reviews. 2016:CD010571. 2016
- The gut microbiome: Potential innovations for the understanding and treatment of psychopathology.. Canadian Psychology. 57:67-75. 2016
- Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database of Systematic Reviews. 2016:CD003840. 2016
- Antidepressants for Functional Dyspepsia: New Indications for Old Therapies?. Clinical Gastroenterology and Hepatology. 14:393-394. 2016
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection. Journal of the American Medical Association (JAMA). 315:142-142. 2016
- Gluten Introduction to Infant Feeding and Risk of Celiac Disease: Systematic Review and Meta-Analysis. Journal of Pediatrics. 168:132-143.e3. 2016
- The Light Shines on: American Journal of Gastroenterology 2015. American Journal of Gastroenterology. 110:1638-1639. 2015
- Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial. Trials. 16:296. 2015
- Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Clinical Respiratory Journal. 2015. 2015
- Lost in Translation: The Gut Microbiota in Psychiatric Illness. Canadian Journal of Psychiatry. 60:460-463. 2015
- Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial. Journal of Medical Screening. 22:158-164. 2015
- Reply. Gastroenterology. 149:826-826. 2015
- Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 149:340-349.e2. 2015
- The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review. Clinical and Translational Gastroenterology. 6:e107-e107. 2015
- Helicobacter pylorieradication for the prevention of gastric neoplasia. Clinical Respiratory Journal. 2015:CD005583. 2015
- Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scandinavian Journal of Gastroenterology, Supplement. 50:816-823. 2015
- Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. American Journal of Gastroenterology. 110:1038-1048. 2015
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 149:102-109.e6. 2015
- Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 64:1049-1057. 2015
- No increase in prevalence of somatization in functional vs organic dyspepsia: a cross‐sectional survey. Neurogastroenterology and Motility. 27:1024-1031. 2015
- Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. American Journal of Gastroenterology. 110:943-943. 2015
- BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (vol 110, pg 662, 2015). American Journal of Gastroenterology. 110:943-943. 2015
- Anti-inflammatory Intervention in Depression. JAMA psychiatry. 72:512-512. 2015
- BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. American Journal of Gastroenterology. 110:662-682. 2015
- Lack of Utility of Symptoms and Signs at First Presentation as Predictors of Inflammatory Bowel Disease in Secondary Care. American Journal of Gastroenterology. 110:716-724. 2015
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts. Gastroenterology. 148:819-822. 2015
- American Gastroenterological Association Technical Review on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts. Gastroenterology. 148:824-848.e22. 2015
- Management of Pancreatic Cysts in an Evidence-Based World. Gastroenterology. 148:692-695. 2015
- Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Alimentary Pharmacology and Therapeutics. 41:449-458. 2015
- Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus. Gastroenterology. 148:367-378. 2015
- Response to Atreja et al.. American Journal of Gastroenterology. 110:346-347. 2015
- Helicobacter pyloriInfection. BioMed Research International. 2015:1-2. 2015
- Tax-Deductible Provisions for Gluten-Free Diet in Canada Compared with Systems for Gluten-Free Diet Coverage Available in Various Countries. Canadian Journal of Gastroenterology and Hepatology. 29:104-110. 2015
- Proton Pump Inhibitors and Risk of Bone Fractures. Current Treatment Options in Gastroenterology. 12:414-423. 2014
- Review: Fiber supplementation improves symptoms in the irritable bowel syndrome. ACP journal club. 161:JC10-JC10. 2014
- Bead study: a novel method to measure gastrointestinal transit in mice. Neurogastroenterology and Motility. 26:1663-1668. 2014
- Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis. American Journal of Gastroenterology. 109:1547-1561. 2014
- Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 109:1350-1365. 2014
- The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. American Journal of Gastroenterology. 109:1367-1374. 2014
- American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. American Journal of Gastroenterology. 109:S2-S26. 2014
- Proton pump inhibitors for functional dyspepsia. Clinical Respiratory Journal. 2014. 2014
- Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 109:811-819. 2014
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. The BMJ. 348:g3174-g3174. 2014
- Whom should we "test and treat" for Helicobacter pylori?. The BMJ. 348:g3320. 2014
- Whom should we "test and treat" for Helicobacter pylori?. The BMJ. 348:g3320-g3320. 2014
- Review: Calprotectin testing differentiates inflammatory bowel disease from the irritable bowel syndrome. ACP journal club. 160:JC13-JC13. 2014
- Rates of upper gastrointestinal endoscopy and gastro-oesophageal malignancy outcomes. Gut. 63:703.1-703. 2014
- The Rome III Criteria for the Diagnosis of Functional Dyspepsia in Secondary Care Are Not Superior to Previous Definitions. Gastroenterology. 146:932-940.e1. 2014
- Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria. Alimentary Pharmacology and Therapeutics. 39:312-321. 2014
- Reply to Kawakami et al.. Endoscopy. 46:164-164. 2014
- British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 63:7-42. 2014
- Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy. Canadian Journal of Gastroenterology and Hepatology. 28:66-68. 2014
- Optimum duration of regimens forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews. 12:CD008337. 2013
- Randomized controlled trial comparing telephone and mail follow-up for recruitment of participants into a clinical trial of colorectal cancer screening. Trials. 14:40. 2013
- Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Gastroenterology. 145:1262-1270.e1. 2013
- Crohn disease was not associated with increased risk for mortality. ACP journal club. 159:JC12-JC12. 2013
- Dyspepsia. Current Opinion in Gastroenterology. 29:662-668. 2013
- The authors reply. Critical Care Medicine. 41:e397-e398. 2013
- Gamma-amino butyric acid (GABA) receptor agonists for gastroesophageal reflux disease (GERD). Clinical Respiratory Journal. 2013. 2013
- Canadian association of gastroenterology position statement: Hip fracture and proton pump inhibitor therapy -a 2013 update. Canadian Journal of Gastroenterology. 27. 2013
- Response to Nahon et al. and Marmo et al.. American Journal of Gastroenterology. 108:1534-1535. 2013
- Dyspepsia. The BMJ. 347:f5059-f5059. 2013
- Dyspepsia.. The BMJ. 347:f5059. 2013
- Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 45:605-618. 2013
- High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitis. Clinical Respiratory Journal. 2013. 2013
- Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP). Clinical Respiratory Journal. 2013. 2013
- Assessing the Value of Symptom Relief for Patients with Gastroesophageal Reflux Disease Treatment: Willingness to Pay Using a Discrete Choice Experiment. Value in Health. 16:588-598. 2013
- Management of reflux-related symptoms. Best Practice and Research in Clinical Gastroenterology. 27:387-400. 2013
- Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux disease. Cochrane Database of Systematic Reviews. 2013. 2013
- The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care. Alimentary Pharmacology and Therapeutics. 37:730-737. 2013
- Effect of Comorbidity on Mortality in Patients With Peptic Ulcer Bleeding: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 108:331-345. 2013
- Helicobacter pylori infection in functional dyspepsia. Nature Reviews Gastroenterology and Hepatology. 10:168-174. 2013
- Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients. Critical Care Medicine. 41:693-705. 2013
- Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 185:E156-E166. 2013
- Peripheral Mechanisms in Irritable Bowel Syndrome. New England Journal of Medicine. 368:577-579. 2013
- Peripheral mechanisms in irritable bowel syndrome.. New England Journal of Medicine. 368:578-579. 2013
- Peripheral mechanisms in irritable bowel syndrome.. New England Journal of Medicine. 368:578. 2013
- Peripheral mechanisms in irritable bowel syndrome.. New England Journal of Medicine. 368:577-578. 2013
- Ulcerative colitis. The BMJ. 346:f432-f432. 2013
- Ulcerative colitis.. The BMJ. 346:f432. 2013
- Stoking the Flame: The American Journal of Gastroenterology 2013. American Journal of Gastroenterology. 108:162-165. 2013
- The natural history of gastro‐oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10‐year follow‐up study. Alimentary Pharmacology and Therapeutics. 37:323-331. 2013
- Acid-Suppressive Therapy With Esomeprazole for Relief of Unexplained Chest Pain in Primary Care: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Gastroenterology. 108:56-64. 2013
- Canadian Association of Gastroenterology Position Statement: Hip Fracture and Proton Pump Inhibitor Therapy – a 2013 Update. Canadian Journal of Gastroenterology and Hepatology. 27:593-595. 2013
- Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database of Systematic Reviews. 12:CD009662. 2012
- Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit. Histopathology. 61:795-800. 2012
- Dyspepsia. Current Opinion in Gastroenterology. 28:602-607. 2012
- Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nature Genetics. 44:1131-1136. 2012
- Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process. Gastroenterology. 143:336-346. 2012
- Review article: current treatment options and management of functional dyspepsia. Alimentary Pharmacology and Therapeutics. 36:3-15. 2012
- Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines. ACP journal club. 156:809-809. 2012
- Effect of Dyspepsia on Survival: A Longitudinal 10-Year Follow-Up Study. American Journal of Gastroenterology. 107:912-921. 2012
- Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis. Clinical Gastroenterology and Hepatology. 10:513-519. 2012
- Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemporary Clinical Trials. 33:523-533. 2012
- Iron Overload in Human Disease. New England Journal of Medicine. 366:1548-1550. 2012
- Does aspirin really reduce the risk of colon cancer?. The Lancet. 379:1586-1587. 2012
- Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology. 10:234-239. 2012
- Response to Doherty and Moss. American Journal of Gastroenterology. 107:487-488. 2012
- The risks of PPI therapy. Nature Reviews Gastroenterology and Hepatology. 9:132-139. 2012
- Stress ulcer prophylaxis in critically ill patients: review of the evidence. Polskie Archiwum Medycyny Wewnetrznej. 122:107-114. 2012
- Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 107:167-176. 2012
- Response to Kayhan et al.. American Journal of Gastroenterology. 107:321-322. 2012
- Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature. PLoS ONE. 7:e49163-e49163. 2012
- Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:2070-2077. 2011
- Helicobacter pylori Eradication for Functional Dyspepsia: What Are We Treating?. JAMA Internal Medicine. 171:1936-1936. 2011
- Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on "Helicobacter pylori eradication in functional dyspepsia".. Archives of Internal Medicine. 171:1936-1937. 2011
- Response to Atreja et al.. American Journal of Gastroenterology. 106:2046-2046. 2011
- Response to Yang et al.. American Journal of Gastroenterology. 106:2044-2044. 2011
- Reply to Akobeng. American Journal of Gastroenterology. 106:1857-1858. 2011
- Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile. Inflammatory Bowel Diseases. 17:1540-1546. 2011
- Aspirin in the prevention of cancer. The Lancet. 377:1649-1650. 2011
- Corrigendum: Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:1014-1014. 2011
- An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease. American Journal of Gastroenterology. 106:S2-S25. 2011
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:661-673. 2011
- Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:617-629. 2011
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:601-616. 2011
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:644-659. 2011
- Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:630-642. 2011
- Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:590-599. 2011
- 5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 106:413-420. 2011
- Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: the More Things Change, the More They Stay the Same. Gastroenterology Clinics of North America. 40:87-103. 2011
- Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews. 2:CD002096. 2011
- Medical treatments in the short term management of reflux oesophagitis. Cochrane Database of Systematic Reviews. 2:CD003244. 2011
- Pharmacological interventions for non-ulcer dyspepsia. Clinical Respiratory Journal. 2011:CD001960. 2011
- Psychological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews. 2011:CD002301. 2011
- Reply. Gastroenterology. 140:728-729. 2011
- Does long term aspirin prevent cancer?. The BMJ. 341:c7326-c7326. 2010
- A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire. Internal and emergency medicine. 5:501-506. 2010
- The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial. American Journal of Gastroenterology. 105:2341-2346. 2010
- What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 8:830-837.e2. 2010
- Response to Cappell. American Journal of Gastroenterology. 105:1901-1902. 2010
- Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews. 2010:CD005415. 2010
- Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome. Alimentary Pharmacology and Therapeutics. 32:144-158. 2010
- Cost‐utility analysis of proton pump inhibitors and other gastro‐protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti‐inflammatory agents. Alimentary Pharmacology and Therapeutics. 31:1354-1364. 2010
- Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 59:605-611. 2010
- Prevalence of Uninvestigated Dyspepsia 8 Years After a Large Waterborne Outbreak of Bacterial Dysentery: A Cohort Study. Gastroenterology. 138:1727-1736. 2010
- Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia. Clinical Gastroenterology and Hepatology. 8:401-409. 2010
- Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis. Gastroenterology. 138:1502-1513. 2010
- Methodology for Randomized Trials of Patients With Nonvariceal Upper Gastrointestinal Bleeding: Recommendations From an International Consensus Conference. American Journal of Gastroenterology. 105:540-550. 2010
- The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 59:325-332. 2010
- “Power” of Selective Serotonin Reuptake Inhibitors in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. 8:313-314. 2010
- Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database of Systematic Reviews. 2:CD003245. 2010
- Errors in the Conduct of Systematic Reviews of Pharmacological Interventions for Irritable Bowel Syndrome. American Journal of Gastroenterology. 105:280-288. 2010
- The American College of Gastroenterology Irritable Bowel Syndrome Monograph: Translating Systematic Review Data to Clinical Practice. Gastroenterology. 138:789-791. 2010
- International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. ACP journal club. 152:101-101. 2010
- Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability. American Journal of Gastroenterology. 105:65-73. 2010
- Passing the Torch: The American Journal of Gastroenterology 2010. American Journal of Gastroenterology. 105:4-7. 2010
- Sequential Therapy for Eradication of Helicobacter pylori: A New Guiding Light or a False Dawn?. American Journal of Gastroenterology. 104:3081-3083. 2009
- Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 7:1279-1286. 2009
- Initial management strategies for dyspepsia. Clinical Respiratory Journal. 2010:CD001961. 2009
- Redundant Data in the Meta-analysis onHelicobacter pyloriEradication. ACP journal club. 151:513-513. 2009
- Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials. Diseases of the Colon and Rectum. 52:1805-1805. 2009
- Helicobacter pylori infection.. American Family Physician. 2009:0406. 2009
- Bran's deleterious effects: much ado about nothing. The BMJ. 339:b3956-b3956. 2009
- Is it safe to use a proton pump inhibitor with clopidogrel?. Polskie Archiwum Medycyny Wewnetrznej. 119:564-568. 2009
- Managing dyspepsia. Current Gastroenterology Reports. 11:288-294. 2009
- Treatment of chronic gastro-oesophageal reflux disease. The BMJ. 339:b2481-b2481. 2009
- 10‐biomarker algorithm to identify irritable bowel syndrome. Alimentary Pharmacology and Therapeutics. 30:95-96. 2009
- Alarm features of colorectal cancer Reply. Gut. 58:1026-1027. 2009
- Authors' reply. Gut. 58:1026-1027. 2009
- Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 104:1831-1843. 2009
- Meta‐analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Alimentary Pharmacology and Therapeutics. 30:28-36. 2009
- Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?. Polskie Archiwum Medycyny Wewnetrznej. 119:391-396. 2009
- Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms? (vol 300, pg 1793, 2008). Journal of the American Medical Association (JAMA). 301:1544-1544. 2009
- Yield of Diagnostic Tests for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome. JAMA Internal Medicine. 169:651-651. 2009
- An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome (vol 104, pg S1, 2009). American Journal of Gastroenterology. 104:1072-1072. 2009
- Testing for Celiac Disease in Patients With Symptoms of Irritable Bowel Syndrome—Reply. Journal of the American Medical Association (JAMA). 301:1126-1126. 2009
- Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Alimentary Pharmacology and Therapeutics. 29:481-496. 2009
- Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 58:367-378. 2009
- GERD in Adults. American Family Physician. 79:149-150. 2009
- An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 104:S1-S35. 2009
- Diagnosis and Management of Non-Erosive Reflux Disease – The Vevey NERD Consensus Group. Digestion. 80:74-88. 2009
- Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?. Canadian Journal of Gastroenterology and Hepatology. 23:251-252. 2009
- CON: Evidence-Based Medicine-The Emperor's New Clothes?. American Journal of Gastroenterology. 103:2967-2969. 2008
- Pro: EBM: an invaluable tool for medical practice.. American Journal of Gastroenterology. 103:2965-2967. 2008
- Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. The BMJ. 337:a2313-a2313. 2008
- Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut. 57:1545-1553. 2008
- Optimizing Surveillance in Barrett's Esophagus: Response to Ruggeet al.. American Journal of Gastroenterology. 103:2946-2947. 2008
- Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms?. Journal of the American Medical Association (JAMA). 300:1793-1793. 2008
- Fluctuation of gastrointestinal symptoms in the community: a 10‐year longitudinal follow‐up study. Alimentary Pharmacology and Therapeutics. 28:1013-1020. 2008
- Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm. American Journal of Gastroenterology. 103:2428-2431. 2008
- Response:. Gastrointestinal Endoscopy. 68:810-811. 2008
- Meta‐analysis: Helicobacter pylori‘test and treat’ compared with empirical acid suppression for managing dyspepsia. Alimentary Pharmacology and Therapeutics. 28:534-544. 2008
- The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview. Digestive Diseases and Sciences. 53:2293-2299. 2008
- Clinical trial design in adult reflux disease: a methodological workshop. Alimentary Pharmacology and Therapeutics. 28:107-126. 2008
- GORD in adults.. Clinical Evidence. 2008:0403. 2008
- Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior. American Journal of Gastroenterology. 103:1229-1239. 2008
- Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial. American Journal of Gastroenterology. 103:1079-1089. 2008
- Mortality risks associated with Barrett’s oesophagus: authors' reply. Alimentary Pharmacology and Therapeutics. 27:853-854. 2008
- Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). The BMJ. 336:651-654. 2008
- Asia–Pacific consensus guidelines on gastric cancer prevention. Journal of Gastroenterology and Hepatology. 23:351-365. 2008
- Gastric Cancer Consensus Conference RecommendsHelicobacter pyloriScreening and Treatment in Asymptomatic Persons From High-Risk Populations to Prevent Gastric Cancer. American Journal of Gastroenterology. 103:510-514. 2008
- Barrett's Esophagus and Obesity: The Missing Part of the Puzzle. American Journal of Gastroenterology. 103:301-303. 2008
- EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointestinal Endoscopy. 67:235-244. 2008
- Mortality rates in patients with Barrett’s oesophagus. Alimentary Pharmacology and Therapeutics. 27:316-320. 2008
- A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States. Medical decision making. 28:44-55. 2008
- Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis. World Journal of Gastroenterology. 14:7361-7361. 2008
- Current Guidelines for Dyspepsia Management. Digestive Diseases. 26:225-230. 2008
- Hip Fracture and Proton Pump Inhibitor Therapy: Position Statement. Canadian Journal of Gastroenterology and Hepatology. 22:855-856. 2008
- La Fracture de la Hanche et la Thérapie par Inhibiteurs de la Pompe à Protons : Un Document de Principes. Canadian Journal of Gastroenterology and Hepatology. 22:857-858. 2008
- Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study. International Journal of Epidemiology. 36:1327-1333. 2007
- Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technology Assessment. 11:iii-164. 2007
- Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technology Assessment. 11:1-+. 2007
- Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia‐related resource use. Alimentary Pharmacology and Therapeutics. 26:1267-1275. 2007
- Die Montreal-Definition und -Klassifikation der gastroösophagealen Refluxkrankheit: Ein globales evidenzbasiertes Konsensus-Papier. Zeitschrift für Gastroenterologie. 45:1125-1140. 2007
- Should triple therapy for Helicobacter pylori eradication be prescribed for 1 week or 2 weeks?. Nature Reviews Gastroenterology and Hepatology. 4:596-597. 2007
- Detection of Intestinal Metaplasia in Barrett's Esophagus. American Journal of Gastroenterology. 102:2353-2354. 2007
- Sequential regimens for Helicobacter pylori eradication. The Lancet. 370:1010-1012. 2007
- Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression. American Journal of Gastroenterology. 102:2047-2056. 2007
- Colorectal cancer screening lacks evidence of benefit.. Cleveland Clinic Journal of Medicine. 74:545-545. 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 56:772-781. 2007
- Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies. American Journal of Gastroenterology. 102:1154-1161. 2007
- Review: eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H pylori infection. BMJ Evidence-Based Medicine. 12:84-84. 2007
- Review: Eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H. pylori infection. ACP journal club. 146:63-63. 2007
- Who Consults With Dyspepsia? Results from a Longitudinal 10-Yr Follow-Up Study. American Journal of Gastroenterology. 102:957-965. 2007
- Medical treatments in the short term management of reflux oesophagitis. Clinical Respiratory Journal. CD003244. 2007
- The health economics of Helicobacter pylori infection. Best Practice and Research in Clinical Gastroenterology. 21:347-361. 2007
- Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut. 56:321-327. 2007
- International Comparisons of Manpower in Gastroenterology. American Journal of Gastroenterology. 102:478-481. 2007
- The Short‐Form Leeds Dyspepsia Questionnaire validation study. Alimentary Pharmacology and Therapeutics. 25:477-486. 2007
- A European view of diagnostic yield and appropriateness of colonoscopy.. Hepato-Gastroenterology: current medical and surgical trends. 54:729-735. 2007
- Recommendations on Chronic Constipation (including Constipation Associated with Irritable Bowel Syndrome) Treatment. Canadian Journal of Gastroenterology and Hepatology. 21:3B-22B. 2007
- The Promises and Perils of Nurse-Led Flexible Sigmoidoscopy Screening. Canadian Journal of Gastroenterology and Hepatology. 21:280-282. 2007
- Variations in colonoscopy practice in Europe: A multicentre descriptive study (EPAGE). Scandinavian Journal of Gastroenterology, Supplement. 42:126-134. 2007
- Who Provides Gastrointestinal Endoscopy in Canada?. Canadian Journal of Gastroenterology and Hepatology. 21:843-846. 2007
- Endoscopic therapy for patients with gastro-esophageal reflux disease (GORD). Cochrane Database of Systematic Reviews. 2006
- Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax. 61:975-979. 2006
- Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews. CD001960. 2006
- Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Clinical Respiratory Journal. CD005415. 2006
- Invited Commentary: Clues to the Etiology of Inflammatory Bowel Disease—A Return to John Snow?. American Journal of Epidemiology. 164:624-626. 2006
- Response to Dr. Zappa and Colleagues. American Journal of Gastroenterology. 101:2433-2434. 2006
- Distinguishing Organic and Functional Dyspepsia by History. Journal of the American Medical Association (JAMA). 296:1352-1352. 2006
- In reply [8]. Journal of the American Medical Association (JAMA). 296:1352-1353. 2006
- Helicobacter pylori and gastro-oesophageal reflux disease – Authors' reply. The Lancet. 368:986-987. 2006
- Limited Value of Alarm Features in the Diagnosis of Upper Gastrointestinal Malignancy: Systematic Review and Meta-analysis. Gastroenterology. 131:390-401. 2006
- The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. American Journal of Gastroenterology. 101:1900-1920. 2006
- Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.. Medscape journal of medicine. 8:88. 2006
- Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.. MedGenMed Medscape General Medicine. 8:66. 2006
- Gastro-oesophageal reflux disease. The Lancet. 367:2086-2100. 2006
- Current Sedation and Monitoring Practice for Colonoscopy: An International Observational Study (EPAGE). Endoscopy. 38:461-469. 2006
- Eradication of Helicobacter pylori for non-ulcer dyspepsia. Clinical Respiratory Journal. CD002096. 2006
- Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database of Systematic Reviews. CD003840. 2006
- Can the Clinical History Distinguish Between Organic and Functional Dyspepsia?. Journal of the American Medical Association (JAMA). 295:1566-1566. 2006
- Colorectal Cancer Screening with Fecal Occult Blood Testing (FOBT): An International Perspective. American Journal of Gastroenterology. 101:212-212. 2006
- Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data. American Journal of Gastroenterology. 101:380-384. 2006
- Canadian Consensus on Medically Acceptable Wait Times for Digestive Health Care. Canadian Journal of Gastroenterology and Hepatology. 20:411-423. 2006
- NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias. The Lancet Oncology. 7:7-8. 2006
- A Community Screening Program for Helicobacter pylori Saves Money: 10-Year Follow-up of a Randomized Controlled Trial. Gastroenterology. 129:1910-1917. 2005
- Gastro-oesophageal reflux disease.. Clinical Evidence. 567-581. 2005
- American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia. Gastroenterology. 129:1756-1780. 2005
- Initial management strategies for dyspepsia. Clinical Respiratory Journal. CD001961. 2005
- PPIs effective for diagnosis, treatment of noncardiac chest pain.. Journal of Family Practice. 54:840. 2005
- Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's Esophagus. American Journal of Epidemiology. 162:454-460. 2005
- Gastroenterologists Overestimate the Appropriateness of Colonoscopies They Perform: An International Observational Study. Endoscopy. 37:840-846. 2005
- Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique. American Journal of Gastroenterology. 100:2100-2115. 2005
- Erratum: Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents - An evidence-based evaluation (Canadian Journal of Gastroenterology (2005) vol. 19 (7) (399-408)). Canadian Journal of Gastroenterology. 19:478. 2005
- Review article: gastro‐oesophageal reflux disease – the extent of the problem. Alimentary Pharmacology and Therapeutics. 22:11-19. 2005
- Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis. American Journal of Gastroenterology. 100:1226-1232. 2005
- Gastro‐oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South‐East Asian patients with dyspepsia. Alimentary Pharmacology and Therapeutics. 21:1483-1490. 2005
- Helicobacter pylori infection.. Clinical Evidence. 518-534. 2005
- Helicobacter pylori “Test and Treat” or Endoscopy for Managing Dyspepsia: An Individual Patient Data Meta-analysis. Gastroenterology. 128:1838-1844. 2005
- Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Alimentary Pharmacology and Therapeutics. 21:1135-1143. 2005
- PROTON PUMP INHIBITORS IN NONULCER DYSPEPSIA: STILL WORKING AFTER ALL THESE YEARS. Evidence-Based Gastroenterology. 6:36-37. 2005
- The association between Helicobacter pylori infection and adult height. European Journal of Epidemiology (EJE). 20:455-465. 2005
- Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Clinical Respiratory Journal. CD003245. 2005
- Psychological interventions for non-ulcer dyspepsia. Clinical Respiratory Journal. CD002301. 2005
- Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?. American Journal of Gastroenterology. 100:534-536. 2005
- Nonulcer dyspepsia and proton pump inhibitors. Gastroenterology. 128:805-805. 2005
- Reply. Gastroenterology. 128:805-806. 2005
- Helicobacter pylori test-and-eradicate strategy versus early endoscopy in patients with dyspepsia. Nature Reviews Gastroenterology and Hepatology. 2:70-71. 2005
- Symptom-Based Outcome Measures for Dyspepsia and GERD Trials: A Systematic Review. American Journal of Gastroenterology. 100:442-452. 2005
- Eradication of Helicobacter pylori for non-ulcer dyspepsia. Clinical Respiratory Journal. CD002096. 2005
- Canadian Helicobacter Study Group Consensus Conference: Update on the Approach to Helicobacter Pylori Infection in Children and Adolescents – an Evidence-Based Evaluation. Canadian Journal of Gastroenterology and Hepatology. 19:399-408. 2005
- Measuring Gastroesophageal Reflux Symptoms: Musings from Marrakech. American Journal of Gastroenterology. 100:19-20. 2005
- Measuring gastroesophageal reflux symptoms: musings from Marrakech.. American Journal of Gastroenterology. 100:19-20. 2005
- Should We Test for Helicobacter Pylori before Treating Gastroesophageal Reflux Disease?. Canadian Journal of Gastroenterology and Hepatology. 19:425-427. 2005
- CON: Patients with GERD Should Be Screened Once at Least for Barrett's Esophagus-Medicine or Magic?. American Journal of Gastroenterology. 99:2293-2295. 2004
- Helicobacter pylori infection.. Clinical Evidence. 641-658. 2004
- Meta-analysis: Can We Mix Apples and Oranges?. American Journal of Gastroenterology. 99:2297-2301. 2004
- The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology. 127:1329-1337. 2004
- Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database of Systematic Reviews. CD003840. 2004
- Pharmacological interventions for non-ulcer dyspepsia. Clinical Respiratory Journal. CD001960. 2004
- Cost-effectiveness and long-term impact of Helicobacter pylori ???test and treat??? service in reducing open access endoscopy referrals. European Journal of Gastroenterology and Hepatology. 16:981-986. 2004
- A Systematic Review of Psychological Therapies for Nonulcer Dyspepsia. American Journal of Gastroenterology. 99:1817-1822. 2004
- Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis. American Journal of Gastroenterology. 99:1833-1855. 2004
- Helicobacter pylori Public Health Implications. Helicobacter. 9:67-72. 2004
- Eradicating H pylori. The BMJ. 328:1388-1389. 2004
- Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus. Journal of the National Cancer Institute. 96:885-887. 2004
- A glossary of economic terms. European Journal of Gastroenterology and Hepatology. 16:563-565. 2004
- A glossary of economic terms. European Journal of Gastroenterology and Hepatology. 16:563-565. 2004
- Cost-utility and cost-benefit analyses. European Journal of Gastroenterology and Hepatology. 16:527-534. 2004
- Gastro-oesophageal reflux disease.. Clinical Evidence. 583-600. 2004
- A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. Gut. 53:iv58-iv65. 2004
- Bringing science to the art of diagnosis. Gut. 53:627-628. 2004
- New approaches to enhance the accuracy of the diagnosis of reflux disease. Gut. 53:iv55-iv57. 2004
- Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 53:iv1-iv24. 2004
- Methods and Economic Considerations: Group 1 Report. Endoscopy. 36:349-353. 2004
- Eradikationstherapie bei Helicobacter-pylori-positiven Patienten mit Ulkuskrankheit. Praxis: a journal of writing and building. 93:566-566. 2004
- The methodological quality of trials affects estimates of treatment efficacy in functional (non‐ulcer) dyspepsia. Alimentary Pharmacology and Therapeutics. 19:631-641. 2004
- Uninvestigated dyspepsia and non‐ulcer dyspepsia—the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy. Alimentary Pharmacology and Therapeutics. 19:1-8. 2004
- Psychological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews. CD002301. 2004
- Psychological interventions for non-ulcer dyspepsia. Clinical Respiratory Journal. CD002301. 2004
- An Update of The Cochrane Systematic Review of Helicobacter Pylori Eradication Therapy in Nonulcer Dyspepsia: Resolving The Discrepancy Between Systematic Reviews. American Journal of Gastroenterology. 98:2621-2626. 2003
- An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.. American Journal of Gastroenterology. 98:2621-2626. 2003
- Helicobacter pylori infection.. Clinical Evidence. 535-548. 2003
- JournalScan. Gut. 52:1653-1654. 2003
- Dyspepsia results may not apply in primary care. The BMJ. 327:811. 2003
- JournalScan. Gut. 52:1382-1382. 2003
- JournalScan. Gut. 52:1219-1219. 2003
- Gastro-oesophageal reflux disease.. Clinical Evidence. 496-512. 2003
- Helicobacter pylori infection.. American Family Physician. 67:2359-2360. 2003
- Mycophenolate mofetil in refractory inflammatory bowel disease. Alimentary Pharmacology and Therapeutics. 17:1365-1369. 2003
- Systematic review: antacids, H2‐receptor antagonists, prokinetics, bismuth and sucralfate therapy for non‐ulcer dyspepsia. Alimentary Pharmacology and Therapeutics. 17:1215-1227. 2003
- Eradication of Helicobacter pylori for non-ulcer dyspepsia.. Cochrane Database of Systematic Reviews. CD002096. 2003
- Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Clinical Respiratory Journal. CD003840. 2003
- Helicobacter pylori infection in subjects with acute ischaemic stroke. Digestive and Liver Disease. 35:16-19. 2003
- How Can the Current Strategies for Helicobacter pylori Eradication Therapy be Improved?. Canadian Journal of Gastroenterology and Hepatology. 17:36B-40B. 2003
- Initial management strategies for dyspepsia. Cochrane Database of Systematic Reviews. CD001961. 2003
- Pharmacological interventions for non-ulcer dyspepsia. Clinical Respiratory Journal. CD001960. 2003
- Recent developments in gastroenterology. The BMJ. 325:1399-1402. 2002
- Helicobacter pylori infection.. Clinical Evidence. 453-468. 2002
- Helicobacter pylori and nonmalignant disease. Helicobacter. 7:30-36. 2002
- Bile reflux gastritis and intestinal metaplasia at the cardia. Gut. 51:351-355. 2002
- Helping patients to help themselves: the future for management of ulcerative colitis?. Gut. 51:309-310. 2002
- Helicobacter pylori infection.. Clinical Evidence. 414-428. 2002
- Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. International Journal of Epidemiology. 31:624-631. 2002
- Helicobacter pylori Eradication Therapy for Nonulcer Dyspepsia. ACP journal club. 136:555-555. 2002
- Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysis. European Journal of Gastroenterology and Hepatology. 14:429-433. 2002
- Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology. 14:249-256. 2002
- The cost‐effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Alimentary Pharmacology and Therapeutics. 16:559-568. 2002
- Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology. 122:588-590. 2002
- Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology. 121:1120-1126. 2001
- Counting the cost of proton pump inhibitors. Gut. 49:462-463. 2001
- Acridine orange stain in the histological identification of Helicobacter pylori. Journal of Clinical Pathology - Clinical Molecular Pathology. 54:734-734. 2001
- Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?. Gut. 49:359-363. 2001
- Dyspepsia: The Clinical Consequences.. Gut. 49:314.1-314. 2001
- Helicobacter pylori: a clinical update. Journal of Applied Microbiology. 90:126S-133S. 2001
- Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients (vol 33, pg 132, 2001). Digestive and Liver Disease. 33:392-392. 2001
- Initial management strategies for dyspepsia. Praxis. 90:737. 2001
- Randomised study ofefficacy of Omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients. Digestive and Liver Disease. 33:131-134. 2001
- Review: prokinetics and histamine-2 receptor antagonists improve symptom scores in non-ulcer dyspepsia. BMJ Evidence-Based Medicine. 6:47-47. 2001
- Initial management strategies for dyspepsia.. Cochrane Database of Systematic Reviews. CD001961. 2001
- Psychological interventions for non-ulcer dyspepsia. Clinical Respiratory Journal. CD002301. 2001
- Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression. Helicobacter. 5:206-214. 2000
- Histological identification ofHelicobacter pylori: comparison of staining methods. Journal of Clinical Pathology - Clinical Molecular Pathology. 53:756-759. 2000
- Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. The BMJ. 321:659-664. 2000
- The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Alimentary Pharmacology and Therapeutics. 14:719-728. 2000
- The proportion of upper gastrointestinal symptoms in the community associated with helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. American Journal of Gastroenterology. 95:1448-1455. 2000
- Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. The Lancet. 355:1665-1669. 2000
- Eradicating war is essential to eliminate poverty and improve health. The BMJ. 320:1208-1208. 2000
- Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Studies included in meta-analysis had heterogenous, not homogenous, results.. The BMJ. 320:1208. 2000
- Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? This meta-analysis is potentially misleading.. The BMJ. 320:1208-1209. 2000
- Finding the optimum treatment for Helicobacter pylori. Digestive and Liver Disease. 32:116-118. 2000
- Eradication of helicobacter pylori for non-ulcer dyspepsia.. Cochrane Database of Systematic Reviews. CD002096. 2000
- Initial management strategies for dyspepsia.. Cochrane Database of Systematic Reviews. CD001961. 2000
- Pharmacological interventions for non-ulcer dyspepsia.. Cochrane Database of Systematic Reviews. CD001960. 2000
- The management of dyspepsia: a systematic review.. Health Technology Assessment. 4:iii-189. 2000
- The Usefulness of The Likelihood Ratio in The Diagnosis of Dyspepsia and Gastroesophageal Reflux Disease. American Journal of Gastroenterology. 94:3122-3125. 1999
- The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia. European Journal of Gastroenterology and Hepatology. 11:1245-1250. 1999
- 5‐Day H. pylori eradication. Alimentary Pharmacology and Therapeutics. 13:1252-1252. 1999
- Reply — 5‐Day H. pylori eradication. Alimentary Pharmacology and Therapeutics. 13:1253-1253. 1999
- Do young dyspeptics require endoscopy any more?. European Journal of Gastroenterology and Hepatology. 11:S63-S63. 1999
- Should we go further and screen and treat? Discussion III. European Journal of Gastroenterology and Hepatology. 11:S73-S73. 1999
- Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. American Journal of Kidney Diseases. 33:1049-1057. 1999
- Correlation between epithelial cell proliferation and histological grading in gastric mucosa.. Journal of Clinical Pathology - Clinical Molecular Pathology. 52:367-371. 1999
- The optimal antibiotic combination in a 5‐day Helicobacter pylori eradication regimen. Alimentary Pharmacology and Therapeutics. 13:497-501. 1999
- POPULATION-BASED AND OPPORTUNISTIC SCREENING AND ERADICATION OF HELICOBACTER PYLORI. International Journal of Technology Assessment in Health Care. 15:649-660. 1999
- The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Alimentary Pharmacology and Therapeutics. 12:1257-1262. 1998
- Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. Journal of Gastroenterology. 33:160-163. 1998
- The Serum 13C‐Bicarbonate Assay: A Replacement for Urea Breath Tests? Vector Potential of Houseflies (Musca domestica) for Helicobacter pylori. Reflux Esophagitis in Duodenal Ulcer Patients. Helicobacter. 3:64-67. 1998
- Genetic variability and characterization of non-structural region 5 of hepatitis C virus genome from Chinese patients. Journal of Gastroenterology. 33:62-72. 1998
- Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for. British Medical Bulletin. 54:243-250. 1998
- What is the optimum strategy for managing dyspepsia?. Journal of Gastroenterology. 33 Suppl 10:44-47. 1998
- Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?. Digestive and Liver Disease. 29:506-508. 1997
- Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardioscience. 35:120-124. 1997
- Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. The BMJ. 314:1688-1688. 1997
- Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection - Reply. The BMJ. 314:1690-1691. 1997
- Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. Conflicting results from the Helisal test.. The BMJ. 314:1688-1689. 1997
- Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin.. Journal of Clinical Pathology - Clinical Molecular Pathology. 50:527-529. 1997
- Do patients need to fast for a 13C-urea breath test?. European Journal of Gastroenterology and Hepatology. 9:275-277. 1997
- Mouth‐Watering Prospects for Helicobacter pylori Diagnosis?. Helicobacter. 2:53-55. 1997
- Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. The BMJ. 314:119-119. 1997
- Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicateHelicobacter pylori. Journal of Gastroenterology. 32:24-27. 1997
- Significance of Helicobacter Pylori Infection and Gastric Cancer: Implications for Screening. Gastrointestinal Endoscopy Clinics of North America. 7:47-64. 1997
- Comparison of One or Two Weeks of Lansoprazole, Amoxicillin, and Clarithromycin in the Treatment of Helicobacter pylori. Helicobacter. 1:71-74. 1996
- OVER THE FENCE. Helicobacter. 1:123-124. 1996
- The Influence of Helicobacter pylori Status on Circulating Levels of the Coagulation Factors Fibrinogen, von Willebrand Factor, Factor VII, and Factor VIII. Helicobacter. 1:65-69. 1996
- Endoscopy and Gastric Ulcers. Endoscopy. 27:689-693. 1995
- Helicobacter pylori: the research explosion. Current Opinion in Infectious Diseases. 8:374-379. 1995
- Mesangiocapillary glomerulonephritis associated with ulcerative colitis: case reports of two patients.. Nephrology Dialysis Transplantation. 10:1923-1924. 1995
- Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.. European Journal of Gastroenterology and Hepatology. 7:835-840. 1995
- Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.. Thorax. 50:834-837. 1995
- SALIVARY ANTIBODIES TO HELICOBACTER-PYLORI - SCREENING DYSPEPTIC PATIENTS BEFORE ENDOSCOPY. The Lancet. 344:1016-1017. 1994
- Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. The Lancet. 344:1016-1017. 1994
- Pseudomonas and Endoscopy. Endoscopy. 26:554-558. 1994
-
preprints